STERIS Long Term Debt 2010-2022 | STE

STERIS long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • STERIS long term debt for the quarter ending December 31, 2022 was $3.002B, a 5.47% decline year-over-year.
  • STERIS long term debt for 2022 was $2.945B, a 78.46% increase from 2021.
  • STERIS long term debt for 2021 was $1.651B, a 43.46% increase from 2020.
  • STERIS long term debt for 2020 was $1.151B, a 2.76% decline from 2019.
STERIS Annual Long Term Debt
(Millions of US $)
2022 $2,945
2021 $1,651
2020 $1,151
2019 $1,183
2018 $1,316
2017 $1,478
2016 $1,568
2015 $621
2014 $493
2013 $492
2012 $210
2011 $210
2010 $210
2009 $210
STERIS Quarterly Long Term Debt
(Millions of US $)
2022-12-31 $3,002
2022-09-30 $2,874
2022-06-30 $2,846
2022-03-31 $2,945
2021-12-31 $3,175
2021-09-30 $3,422
2021-06-30 $3,257
2021-03-31 $1,651
2020-12-31 $1,713
2020-09-30 $1,021
2020-06-30 $1,022
2020-03-31 $1,151
2019-12-31 $1,137
2019-09-30 $1,187
2019-06-30 $1,210
2019-03-31 $1,183
2018-12-31 $1,246
2018-09-30 $1,268
2018-06-30 $1,320
2018-03-31 $1,316
2017-12-31 $1,420
2017-09-30 $1,445
2017-06-30 $1,496
2017-03-31 $1,478
2016-12-31 $1,507
2016-09-30 $1,504
2016-06-30 $1,552
2016-03-31 $1,568
2015-12-31 $1,639
2015-09-30 $830
2015-06-30 $686
2015-03-31 $621
2014-12-31 $611
2014-09-30 $620
2014-06-30 $659
2014-03-31 $493
2013-12-31 $475
2013-09-30 $509
2013-06-30 $514
2013-03-31 $492
2012-12-31 $521
2012-09-30 $434
2012-06-30 $210
2012-03-31 $210
2011-12-31 $210
2011-09-30 $210
2011-06-30 $210
2011-03-31 $210
2010-12-31 $210
2010-09-30 $210
2010-06-30 $210
2010-03-31 $210
2009-12-31 $310
2009-09-30 $210
2009-06-30 $210
2009-03-31 $210
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $18.499B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.492B 24.17
Edwards Lifesciences (EW) United States $49.046B 32.63
Alcon (ALC) Switzerland $33.478B 30.63
Fresenius Medical Care AG KGaA (FMS) Germany $12.188B 12.74
Teleflex (TFX) United States $11.596B 18.91
Penumbra (PEN) United States $10.582B 1630.35
Globus Medical (GMED) United States $5.353B 25.78
Integer Holdings (ITGR) United States $2.578B 19.99
Glaukos (GKOS) United States $2.434B 0.00
Paragon 28 (FNA) United States $1.402B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.348B 17.53
Nevro (NVRO) United States $1.175B 0.00
Artivion (AORT) United States $0.496B 244.80